Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Axelopran by Theravance Biopharma for Opioid-Induced Constipation (OIC): Likelihood of Approval
Axelopran is under clinical development by Theravance Biopharma and currently in Phase II for Opioid-Induced Constipation (OIC). According to GlobalData,...